Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients.

Arzu Cennet IşıkMurat KavasMehmet Engin Tezcan

Published in: Zeitschrift fur Rheumatologie (2022)

We show that MetS is a frequent feature of sarcoidosis even before treatment is started. Therefore, clinicians should be aware of MetS both during treatment and during the course of the disease to reduce the risk of cardiovascular events.

Keyphrases

cardiovascular events
metabolic syndrome
end stage renal disease
cardiovascular disease
newly diagnosed
type diabetes
adipose tissue
patient reported outcomes